ATEC
Alphatec Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$8.27
+10.64%Year over year
Reported trailing growth
- Revenue
- +15.3%
- EBITDA
- +204.7%
- EBIT
- +73.1%
- EPS
- +46.2%
- Free cash flow
- —
- Operating cash flow
- +74.9%
Forward estimates
Based on analyst estimates
- Revenue
- +12.9%
- EBITDA
- +635.2%
- EPS
- +191.9%
Three-year CAGR
- Revenue
- +29.6%
- EBITDA
- +26.3%
- EBIT
- +39.7%
- Net income
- +11.6%
- EPS
- +15.0%
- Free cash flow
- +102.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026